• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

News

Article

Recap: 2024 Society for Pediatric Dermatology Annual Meeting

Catch up on coverage from the 2024 Society for Pediatric Dermatology Annual Meeting in Toronto, Ontario, Canada.

SPD Conference Recap

To stay informed with the latest conference insights, subscribe to receive our E-newsletters.

POLL: What Are You Most Looking Forward to Learning at the 2024 Society for Pediatric Dermatology Annual Meeting?

Ahead of the SPD's Annual Meeting in Toronto, share with us: What do you hope to learn?

Previewing the 2024 Society for Pediatric Dermatology Annual Meeting: What to Expect

The conference aimed at providing pediatric dermatology clinicians with the latest in the specialty begins tomorrow in Toronto, Ontario.

Q&A: Diagnostic and Therapeutic Pearls for Pediatric Dermatology

Mancini discusses his SPD 2024 lecture, emphasizing off-label treatments, surrogate diagnostic markers, simpler therapies, and the importance of empathy and education.

Nonthermal Atmospheric Plasma Deemed Safe, Efficacious in Pediatric Verruca Vulgaris and Molluscum Contagiosum

The average pain score reported during treatment was 0.4/10, according to a poster presented at the SPD's annual meeting.

Meena Julapalli, MD: Finding and Prioritizing Joy in the Pediatric Dermatology Specialty

Julapalli discusses her SPD 2024 lecture, "Rediscovering Joy in our Lives and the Workplace," excitement for the future of pediatric dermatology, and more.

Ixekizumab Yields Early, Sustained Improvements to Quality of Life Measures in Pediatric Patients With Plaque Psoriasis

All domains of the DLQI and CDLQI experienced improvements through 108 weeks, according to a poster presented at the SPD's annual meeting.

PODCAST: Navigating Artificial Intelligence in Medicine Featuring Albert Yan, MD, FAAP, FAAD

In this episode, Albert Yan, MD, FAAP, FAAD, discusses his SPD 2024 session revolving around the helpful (or hindering?) role of artificial intelligence and chatbots in dermatology.

HS in Children and Adolescents: Obesity-Related Treatment and Comorbidity Patterns

Hypertension and hyperlipidemia are common among obese pediatric patients with hidradenitis suppurativa, according to a poster presented at the SPD's annual meeting.

Day 1 Recap: 2024 Society for Pediatric Dermatology Annual Meeting

Catch up on coverage from the first day of the 2024 Society for Pediatric Dermatology Annual Meeting in Toronto, Ontario, Canada.

Hydrophilic Polymer, Potassium Ferrate 'WoundSeal' is Effective Alternative to Suturing in Punch Biopsies

Use of WoundSeal yielded no observed complications such as infection or bleeding, according to a poster presented at the SPD's annual meeting.

The Dermatologist’s Guide to Systemic Clues: Highlights from the Hurwitz Lecture

Lisa Weibel, MD, delved into skin signs of systemic diseases in the first of 2 Hurwitz lectures to be presented at the SPD's annual meeting.

Peter Lio, MD: Delving Into Disease Progression in Pediatric Atopic Dermatitis

Lio discusses his SPD 2024 non-CME talk, new and exciting innovations in pediatric atopic dermatitis, and more.

Timothy Caulfield, JD: Addressing Misinformation in the Health Care Space

Caulfield discusses his SPD 2024 lecture, "The Misinformation Crisis: How Did We Get Here and What Can We Do?"

Breaking Down Inflammatory Hair Disorders in Children

Marissa Joseph, MD, discussed inflammatory hair disorders in young children, such as CCCA, in a presentation at the SPD's annual meeting.

Amy Paller, MD: Reviewing Top Insights for Clinical Practice From ESPD

Paller discusses her SPD 2024 lecture, "Updates from ISSVA, ESPD, and SID: What You Missed that Could Change Your Practice."

Preliminary Data on Therapy-Free Remission with Dupilumab for Pediatric Atopic Dermatitis

A significant proportion of pediatric patients with AD achieved and maintained clinical remission with dupilumab, according to a poster presented at the SPD's annual meeting.

Day 2 Recap: 2024 Society for Pediatric Dermatology Annual Meeting

Catch up on coverage from the second day of the 2024 Society for Pediatric Dermatology Annual Meeting in Toronto, Ontario, Canada.

Lisa Swanson, MD, FAAD: The Current Topical Landscape for Pediatric Patients

Swanson discusses her SPD 2024 non-CME talk, expanding topical options for young patients, and more.

Optimizing Pediatric Acne Care with Hormonal Therapy

Andrea Zaenglein, MD, discussed the role of patient counseling and addressing "hormone phobia" in young patients treated with hormonal therapies for acne in her SPD 2024 session.

Reviewing the Latest Developments in Pediatric Non-Steroidal Topicals

Nnena Agim, MD, presented a comprehensive update on non-steroidal topical therapies, highlighting off-label uses and recent FDA approvals in a session at the SPD's annual meeting.

John Browning, MD: Medical Errors, Confirmation Bias, and Emerging Therapies in Pediatric Dermatology

Browning discusses his participation in an SPD 2024 panel discussion, the future of pediatric dermatology, and more.

PODCAST: Food Fight - Drs Treat and Oza Debate Eczema Triggers

In this episode, Vikash Oza, MD, and James Treat, MD, discuss their SPD 2024 session (debate) revolving around the topic: Does food trigger eczema?

Topical Isotretinoin Shows Promise in Phase 3 ASCEND Trial for Congenital Ichthyosis

TMB-001 0.05% demonstrates promising efficacy and safety in treating moderate to severe congenital ichthyosis, according to a poster presented at the SPD's annual meeting.

Tapinarof Cream 1% Demonstrates Efficacy in Treating Atopic Dermatitis in Young Patients with Skin of Color

Tapinarof cream 1% has proven to be an effective and safe treatment for atopic dermatitis in diverse populations, according to a poster presented at the SPD's annual meeting.

Day 3 Recap: 2024 Society for Pediatric Dermatology Annual Meeting

Catch up on coverage from the third and final day of the 2024 Society for Pediatric Dermatology Annual Meeting in Toronto, Ontario, Canada.

Oleogel-S10 Proves Effective in Decreasing Dressing Change Frequency and Costs for Epidermolysis Bullosa Patients

Oleogel-10 exhibited potential to alleviate the physical, emotional, and economic strain of dressing changes, according to a poster presented at the SPD's annual meeting.

Reflections on Decision-Making in Pediatric Dermatology

Smidt and Hunt offer insights on navigating pediatric dermatology decision-making, emphasizing learning from clinical scenarios and fostering a culture of feedback and improvement.

Managing Your Pediatric Dermatology Practice and Life: Insights from Brandie Metz, MD, and Megha Tollefson, MD

Metz and Tollefson share insights on efficient practice management, work-life balance, and exciting developments in pediatric dermatology.

AICHI Study Reveals High Prevalence of Pediatric Axillary Hyperhidrosis in Japan and Promising Results with Sofpironium Bromide Gel

The AICHI study found a significant prevalence of severe primary axillary hyperhidrosis in children in Japan, according to a poster presented at the SPD's annual meeting.

To view all conference coverage from SPD, click here.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.